The group found that TB-related targets established in 2018 during a high-level meeting of the United Nations General Assembly are not on...
Over ten million people will develop tuberculosis (TB) in the world this year; over 500,000 of these will have multidrug-resistant tuberculosis (MDR-TB). Some will receive treatment. However, we know little about the best ways of treating drug-resistant TB (DR-TB) and preventing tuberculosis in people who come in contact with DR-TB patients. TB control efforts require new evidence-based knowledge about optimal treatment regimens, prophylaxis, and regimens involving new TB drugs in order to address the growing health threats of MDR-TB and extensively drug-resistant (XDR) TB.
NEWS IN MDR-TB
TAG released newly available TB chapters of its 2020 Pipeline Report. This annual publication reviews progress in research and developmen...
The World Health Organization’s (WHO) Global TB Program welcomes the results from a landmark study on the treatment of drug-susceptible T...
About RESIST-TB
A movement to promote and conduct research on the treatment and prevention of drug-resistant tuberculosis (DR-TB) and provide access to effective cure and prevention of DR-TB throughout the world.
Recent RESIST-TB Products and Presentations
Upcoming webinars and presentations relating to MDR-TB trials and developments.
JOIN THE MOVEMENT!
Get the Latest News & Updates